Hydroxychloroquine and Cognitive Function After Surgery

NCT03025087 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-08-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether hydroxychloroquine decreases the relative leakage of the brain barrier after surgery.

Conditions

  • Individuals Undergoing Cardiac and General Surgery

Interventions

DRUG

Hydroxychloroquine

Participants will be getting hydroxychloroquine

Sponsors & Collaborators

Principal Investigators

  • Joseph P Mathew, MD · Duke Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-19
Primary Completion
2023-05-22
Completion
2024-04-19
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03025087 on ClinicalTrials.gov